Table 4.
Duration of the disease | N/A | < 10 years | 11–20 years | 21–30 years | > 30 years | ||||
---|---|---|---|---|---|---|---|---|---|
No of patients | CG (n = 45) | HT (n = 19) | HT vs CG | HT (n = 20) | HT vs CG | HT (n = 16) | HT vs CG | HT (n = 13) | HT vs CG |
Mean (SD) | Mean (SD) | p-value | Mean (SD) | p-value | Mean (SD) | p-value | Mean (SD) | p-value | |
Latency (ms) | |||||||||
N200 Fz | 211.5 (20.2) | 232.4 (27.9) | 0.001 | 234.2 (30.1) | < 0.001 | 256.9 (34.3) | < 0.001 | 273.4 (33.8) | < 0.001 |
Cz | 211.3 (20.6) | 232.3 (28.9) | 0.001 | 234.5 (29.1) | < 0.001 | 255.9 (33.4) | < 0.001 | 270.4 (32.8) | < 0.001 |
Pz | 212.1 (19.7) | 235.2 (25.4) | 0.002 | 233.4 (28.9) | 0.001 | 256.5 (36.4) | < 0.001 | 268.0 (31.0) | < 0.001 |
P300 Fz | 322.8 (21.2) | 336.3 (21.5) | 0.02 | 347.7 (16.7) | < 0.001 | 358.9 (19.7) | < 0.001 | 370.8 (18.5) | < 0.001 |
Cz | 323.5 (22.3) | 336.4 (21.7) | 0.04 | 347.6 (14.2) | < 0.001 | 359.3 (20.0) | < 0.001 | 373.3 (19.3) | < 0.001 |
Pz | 325.6 (22.9) | 340.6 (20.2) | 0.01 | 348.0 (14.1) | < 0.001 | 359.1 (20.6) | < 0.001 | 373.4 (24.0) | < 0.001 |
Amplitude (uV) | |||||||||
N200 Fz | 4.00 (2.44) | 4.66 (3.88) | 0.41 | 3.58 (2.65) | 0.54 | 2.93 (1.72) | 0.11 | 2.46 (1.93) | 0.14 |
Cz | 3.44 (2.53) | 4.04 (2.92) | 0.42 | 3.39 (2.19) | 0.94 | 3.02 (1.79) | 0.54 | 2.92 (1.52) | 0.48 |
Pz | 3.06 (1.89) | 3.22 (2.39) | 0.77 | 3.03 (2.49) | 0.96 | 2.88 (2.16) | 0.75 | 2.73 (1.49) | 0.57 |
P300 Fz | 8.04 (3.93) | 6.04 (3.19) | 0.05 | 5.89 (4.58) | 0.05 | 5.55 (3.88) | 0.03 | 5.50 (2.82) | 0.03 |
Cz | 8.02 (3.73) | 5.69 (2.66) | 0.01 | 5.94 (4.79) | 0.05 | 5.71 (4.39) | 0.05 | 5.02 (2.41) | < 0.001 |
Pz | 7.86 (3.81) | 4.95 (2.54) | 0.01 | 5.02 (4.26) | 0.001 | 6.16 (4.48) | 0.01 | 3.86 (2.21) | < 0.001 |
CG control group, HT Hashimoto’s thyroiditis, SD standard deviation, Fz frontal region, Cz central region, Pz parietal region.